"Detecting breast cancer with mammography and biopsy is more difficult in women who use estrogen and progestin hormone therapy, according to an analysis of data from the Women's Health Initiative (WHI) trial.Doctors "should be aware that breast cancer diagnosis is more difficult in women using combined hormone therapy," lead researcher Dr. Rowan T. Chlebowski told Reuters Health. Such therapy has a considerable effect on the risks of having an otherwise avoidable mammogram or breast biopsy, he added."
Just wait and see what new problems are discovered when they start mucking unnecessarily with your imaginary fatso hormones.
Posts
No comments:
Post a Comment